Palisade Bio, Inc.
PALI • NASDAQ
Palisade Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO J. D. Finley, with a market cap of $332.2M.
CEOJ. D. Finley
Next Earnings
Upcoming earnings announcement for Palisade Bio, Inc.
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.04
Earnings History
Past 11 earnings reports for Palisade Bio, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | Q3 2025 | -$0.38Est: -$0.29 | -31.0% | - | — |  10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.58Est: -$0.53 | -9.4% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.47Est: -$0.81 | +42.0% | - | — | 10-Q |
| Mar 24, 2025 | Q4 2024 | -$0.69Est: -$2.58 | +73.3% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$2.32Est: -$3.35 | +30.7% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$3.32Est: -$2.93 | -13.3% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$4.59Est: -$4.28 | -7.2% | - | — | 10-Q |
| Mar 26, 2024 | Q4 2023 | -$3.75Est: -$5.10 | +26.5% | - | — | 10-K |
| Nov 10, 2023 | Q3 2023 | -$7.35Est: -$5.10 | -44.1% | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$7.95Est: -$6.75 | -17.8% | - | — | 10-Q |
| May 12, 2023 | Q1 2023 | -$8.10 | — | $250.0K | — | — |